Mode
Text Size
Log in / Sign up
N/A Completed N=76 Randomized Treatment

RestoreSensor Study

Source: ClinicalTrials.gov NCT01106404 ↗
Enrolled (actual)
76
Serious AEs
10.5%
Results posted
Aug 2012
Primary outcomePrimary: Percentage of Subjects With Improved Pain Relief and/or Convenience During the AdaptiveStim Programming Arm Relative to the Manual Programming Arm — 91.2; 82.5; 93.9; 86.8 percentage of participants — p=< 0.001

Summary

The purpose of the study is to gather clinical information on subjects' experiences with and without the use of the new feature of the RestoreSensor implantable neurostimulator (INS).

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage of Subjects With Improved Pain Relief and/or Convenience During the AdaptiveStim Programming Arm Relative to the Manual Programming Arm
91.2; 82.5; 93.9; 86.8 < 0.001 sig
SECONDARY
Percentage of Subjects With Worsened Pain Relief When Using AdaptiveStim Compared to Manual Programming
0; 5.3 —
SECONDARY
Manual Adjustments Presented as Button Presses
20.9; 35.7 < 0.001 sig
SECONDARY
NPRS Scores From Baseline to Follow-up Visits at 10 Weeks and 16 Weeks Post-implant
5.99; 4.22; 5.90; 4.41 < 0.001 sig

Eligibility Criteria

Inclusion Criteria

  • Meets the indications as an appropriate surgical candidate (after successful SCS screening trial) for implant of a neurostimulation system for spinal cord stimulation (SCS) treatment of trunk and/or limb pain, per labeled indications
  • 18 years of age or older
  • Willing and able to attend visits and comply with the study protocol
  • Capable of using the patient programmer and recharging the neurostimulator (INS), able to read and answer questionnaires in English, without assistance of a caregiver
  • Males and non-pregnant females

Exclusion Criteria

  • Has had a prior implantable SCS neurostimulation system
  • Currently enrolled, or plans to enroll in another investigational device or drug trial during the study
  • Has unresolved legal issues related to their pain condition for which they would be receiving neurostimulation
  • Requires cervical placement of leads.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01106404). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search